AI News
08 Dec 2025
Read 9 min
AI in UK general practice: How to avoid legal risks
AI in UK general practice saves GPs admin time and reduces burnout but needs training to avoid errors.
AI in UK general practice is rising fast, with about three in ten GPs now using tools like ChatGPT. That speed brings legal risk: clinical errors, privacy breaches, and unclear liability. This guide shows simple steps—tool vetting, consent, documentation, and safety checks—to keep care safe and defensible.
AI is moving from taboo to tool in everyday GP work. A recent survey found 28% of family doctors already use it to summarise notes, draft letters, or support diagnosis. The benefits are real, but so are the risks. To use AI in UK general practice safely, focus on regulation, consent, data protection, and clear clinical oversight.
Check whether the tool is a medical device for its intended use and has appropriate marking (e.g., UKCA).
Demand a data processing agreement, security documentation, and vendor transparency on model hosting and updates.
Prefer products that meet NHS Data Security and Protection Toolkit standards and align with NICE evidence expectations for digital health.
Run a Data Protection Impact Assessment (DPIA) before deployment.
Use AI as decision support, not decision maker.
Require human review of any diagnostic or triage output.
Set clear boundaries for use (e.g., admin drafting, coding suggestions, patient leaflets) and forbid unsupervised clinical recommendations.
Tell patients when you use AI to draft notes, letters, or advice.
Offer a simple opt-out and record it.
Use plain language about benefits, limits, and privacy.
Do not paste identifiable data into public chatbots.
Minimise data; de-identify where possible; prefer private, encrypted deployments.
Record lawful basis under UK GDPR and follow Caldicott principles.
Enable audit logs and access controls; restrict who can use the tool and for what.
Note in the record when AI supported a task and what you did with the output.
Capture the prompt, key output, tool name, version/date, and clinician’s final judgement.
Keep a register of AI tools in the practice with owners and review dates.
Create a practice SOP that aligns with your ICB’s stance.
Train all staff on safe prompts, privacy, and known failure modes.
Provide a shared prompt library and examples of acceptable use.
Appoint a clinical safety lead and involve your Caldicott Guardian.
Follow NHS clinical risk management standards for digital tools (e.g., DCB0129 for manufacturers and DCB0160 for deployment).
Run pre‑go‑live tests with real-world scenarios and edge cases.
Set up a simple incident pathway: report, review, learn, and update SOPs.
Monitor outputs for bias across age, sex, ethnicity, language, and deprivation.
Offer translated and accessible patient materials when AI is used for education.
Avoid using AI in ways that widen access gaps between affluent and poorer areas.
Red flag symptoms, safeguarding concerns, or suspected sepsis.
Acute mental health crises or suicidal thoughts.
Rare or high‑risk diagnoses where evidence is thin.
When the patient objects or cannot consent.
When data must not leave a secure environment.
Summarise long free‑text notes or hospital letters, then check and edit.
Draft referral letters, sick notes, and patient information sheets with clinician review.
Suggest SNOMED codes for clinician confirmation, not auto‑coding.
Use AI to list differential diagnoses only after you document your own clinical findings.
Force yourself to verify: “What tests or red flags would change management?”
Never let AI draft prescriptions; the clinician must choose and sign.
“I sometimes use secure AI software to help write clearer notes and letters. I check everything myself. Your data stays protected. You can say no to this at any time.”
“If AI suggests ideas, I treat them like a checklist. I decide your care.”
Safety: incidents, near misses, and corrective actions.
Quality: clarity of letters, coding accuracy, guideline adherence.
Equity: access and outcomes across patient groups.
Workforce: burnout scores and retention.
Pick regulated, privacy‑safe tools and complete a DPIA.
Keep the clinician in charge and document AI use in the record.
Be transparent with patients and offer opt‑outs.
Train staff, test before go‑live, and run an incident process.
Monitor equity and avoid widening gaps in care.
Careful design makes adoption safer. About 28% of GPs already use these tools, and more will follow. With strong governance, clear consent, and good documentation, AI in UK general practice can cut admin load, protect patients, and lower legal risk while building trust.
Why legal risk is rising
GPs face a “wild west” of tools with uneven rules across regions. Some boards support AI, others ban it. Doctors worry about liability if an AI suggestion is wrong, and about patient privacy if data leaves secure systems. Many also lack formal training, which increases error risk.Core safeguards for AI in UK general practice
Choose regulated tools
Keep clinicians in charge
Inform patients and get consent
Protect data and privacy
Document your use
Build policy and training
Clinical safety and incident response
Equity and bias checks
When to avoid AI at the point of care
Practical workflows that reduce risk
Low‑risk, high‑value uses
Clinical support with guardrails
What to say to patients
Measuring benefits that matter
Many GPs use saved minutes to cut overtime and reduce burnout. That is a valid outcome. Track more than appointment counts:Key takeaways
(Source: https://www.theguardian.com/society/2025/dec/03/gp-doctors-health-uk-artificial-intelligence-study)
For more news: Click Here
FAQ
Q: How many GPs in the UK are using AI tools like ChatGPT in consultations?
A: About 28% of GPs reported using AI in UK general practice, with 598 of 2,108 survey respondents saying they already used such tools. They are commonly used to produce appointment summaries and to assist diagnosis.
Q: What legal and safety concerns do GPs have about using AI in consultations?
A: GPs worry about professional liability and medico-legal issues, risks of clinical errors, and problems with patient privacy and data security. They are also concerned by a “wild west” lack of regulation and by many clinicians having no formal training, which can increase error risk.
Q: What core safeguards should practices put in place before deploying AI?
A: Practices should choose regulated tools (check medical device status such as UKCA marking), demand data processing agreements, security documentation and vendor transparency, and run a Data Protection Impact Assessment (DPIA). They must also keep clinicians in charge by using AI only as decision support, requiring human review of diagnostic or triage outputs, and aligning tools with NHS Data Security and Protection Toolkit standards and NICE evidence expectations.
Q: How should clinicians document AI use in records to reduce legal risk?
A: Clinicians should note in the record when AI supported a task and what they did with the output, capturing the prompt, key output, tool name and version or date, and the clinician’s final judgement. Practices should also keep a register of AI tools with owners and review dates to support governance.
Q: In which clinical situations should GPs avoid using AI at the point of care?
A: GPs should avoid AI for red flag symptoms, safeguarding concerns, suspected sepsis, acute mental health crises or suicidal thoughts, and rare or high‑risk diagnoses. AI should also not be used when the patient objects or cannot consent, or when data must not leave a secure environment.
Q: What should I tell patients about AI use and consent in their care?
A: Tell patients when you use AI to draft notes, letters or advice, explain benefits and limits in plain language, and offer a simple opt‑out which you record. Emphasise that you check all AI outputs yourself and that the patient can decline AI support at any time.
Q: Which routine tasks are considered low‑risk, high‑value uses of AI in general practice?
A: Low‑risk, high‑value uses include summarising long free‑text notes or hospital letters (with clinician check and edit), drafting referral letters, sick notes and patient information sheets, and suggesting SNOMED codes for clinician confirmation rather than auto‑coding. These tasks save admin time while keeping the clinician responsible for final content.
Q: How should practices measure whether AI adoption is delivering benefits without increasing risk?
A: Practices should track safety metrics (incidents, near misses and corrective actions), quality measures (clarity of letters, coding accuracy, guideline adherence), equity across patient groups, and workforce outcomes such as burnout scores and retention. Monitoring these indicators helps determine if AI in UK general practice reduces administrative burden without widening access gaps.
Contents
